Bahrain begins child screening programme:
This article was originally published in Clinica
Executive Summary
Bahrain is to begin screening 6,000 children for diseases, including sickle cell anaemia, beta thalassaemia and glucose-6 phosphate dehydrogenase (G6PD) deficiency in March 2003. The project is funded by the Bahrain society for hereditary diseases (BSHD) to the tune of BD20,000 ($53,200) and has the backing of the ministries of health and education. BSHD has already begun purchasing the equipment required for the screening programme. It will take the total number of children screened in Bahrain over the past five years to 30,000. Bahrain's current infant screening programme has helped lower the number of children born with hereditary diseases from 2.1% in 1986 to 0.9% today, said Dr Al Arrayed of the Salmaniya Medical Complex genetics department, in Manama.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.